A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

ClinicalTrials.gov ID: NCT06747351

Public ClinicalTrials.gov record NCT06747351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Study identification

NCT ID: NCT06747351
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Takeda; Industry
Enrollment: 59 participants

Conditions and interventions

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Interventions

TAK-881 Biological
HYQVIA Biological
SC Investigational Needle Sets Device

Biological · Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 5, 2025
Primary completion: Jun 24, 2028
Completion: Jun 24, 2028
Last update posted: Jan 19, 2026

2025 – 2028

United States locations

U.S. sites: 16
U.S. states: 12
U.S. cities: 16

Facility	City	State	ZIP	Site status
HonorHealth Neurology	Scottsdale	Arizona	85251	Recruiting
Stanford Neuroscience Health Center	Palo Alto	California	94304	Not yet recruiting
Yale University School of Medicine	New Haven	Connecticut	06510	Not yet recruiting
Neurology Associates	Maitland	Florida	32751	Recruiting
Knight Neurology	Rockledge	Florida	32955	Recruiting
The Washington University	St Louis	Missouri	63130	Not yet recruiting
NYU Langone Health	New York	New York	10016	Recruiting
University of North Carolina (UNC)	Chapel Hill	North Carolina	27599	Recruiting
Duke University Hospital	Durham	North Carolina	27710	Recruiting
Raleigh Neurology Associates	Raleigh	North Carolina	27607	Recruiting
Atrium Health Wake Forest Baptist	Winston-Salem	North Carolina	27157	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Not yet recruiting
Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic - Marquam Hill	Portland	Oregon	97239	Not yet recruiting
Neurology Rare Disease Center	Denton	Texas	76208	Recruiting
The University of Vermont Medical Center	Burlington	Vermont	05401	Not yet recruiting
BCN Research, LLC	Greenfield	Wisconsin	53228	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06747351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 19, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06747351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →